Inhyub Kim

Statistics

Publications

Citations

218

H-Index

Active since

2016

Affiliations

Korea Research Institute of Bioscience and Biotechnology(Current)

Korea University of Science and Technology

Dongguk University

Inhyub Kim is an author at Korea Research Institute of Bioscience and Biotechnology specializing in pharmacology, drug discovery, and cancer pharmacology.

Publications per year

2016–2024

Publications

A Novel Malate Dehydrogenase 2 Inhibitor Suppresses Hypoxia-Inducible Factor-1 by Regulating Mitochondrial Respiration

Hyun Seung Ban, Xuezhen Xu, Kusik Jang et al. · PLoS ONE · 2016 · 88 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17

Methyl 3-(3-(4-(2,4,4-Trimethylpentan-2-yl)phenoxy)-propanamido)benzoate as a Novel and Dual Malate Dehydrogenase (MDH) 1/2 Inhibitor Targeting Cancer Metabolism

Ravi Naik, Hyun Seung Ban, Kyusic Jang et al. · Journal of Medicinal Chemistry · 2017 · 63 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Identification of Targets of the HIF-1 Inhibitor IDF-11774 Using Alkyne-Conjugated Photoaffinity Probes

Hyun Seung Ban, Ravi Naik, Hwan Mook Kim et al. · Bioconjugate Chemistry · 2016 · 32 citations

Medicine, Oncology, Pharmacology +14

CYB5R3 functions as a tumor suppressor by inducing ER stress-mediated apoptosis in lung cancer cells via the PERK-ATF4 and IRE1α-JNK pathways

Joo‐Young Im, Soo Jin Kim, Jong‐Lyul Park et al. · Experimental & Molecular Medicine · 2024 · 20 citations · Full text

Life Sciences, Molecular Biology, Oncology +16

The disubstituted adamantyl derivative LW1564 inhibits the growth of cancer cells by targeting mitochondrial respiration and reducing hypoxia-inducible factor (HIF)-1α accumulation

Inhyub Kim, Minkyoung Kim, Min Kyung Park et al. · Experimental & Molecular Medicine · 2020 · 15 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17

1–5 of 5